| Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More | Frank Vinluan | 09/25/20 | National |
| Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More | Sarah de Crescenzo | 08/07/20 | National |
| Kala to Take Another Shot at FDA Approval With New Dry Eye Drug Data | Sarah de Crescenzo | 03/09/20 | Boston |
| Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs | Frank Vinluan | 08/16/19 | New York |
| Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More | Frank Vinluan | 04/26/19 | National |
| Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More | Frank Vinluan | 12/14/18 | National |
| FDA Approves Kala Pharmaceuticals Drug for Post-Surgery Eye Pain | Frank Vinluan | 08/23/18 | Boston |
